According to the Zhitong Finance App, Peger Biopharmaceutical-B (02565) announced that it will complete the placement of 26.813 million shares on November 10, 2026, with an issue price of HK$2.985 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.